Accipiter Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KND
Kindred Healthcare
KND
|
+$5.26M |
| 2 |
HP
HPQ
|
+$3.65M |
| 3 |
Teva Pharmaceuticals
TEVA
|
+$2.94M |
| 4 |
GTS
Triple-S Management Corporation
GTS
|
+$2.19M |
| 5 |
OSIR
Osiris Therapeutics, Inc. Common Stock
OSIR
|
+$739K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$12.3M |
| 2 |
Elevance Health
ELV
|
+$6.47M |
| 3 |
AET
Aetna Inc
AET
|
+$5.76M |
| 4 |
ESRX
Express Scripts Holding Company
ESRX
|
+$10.3K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 48.53% |
| 2 | Healthcare | 41.83% |
| 3 | Technology | 9.64% |
Similar funds
Accipiter Capital Management's Q3 2013 Portfolio in Review
As of Q3 2013, Accipiter Capital Management held 10 positions worth $109M, down 15% from $127M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Accipiter Capital Management withdrew a net $9.46M in Q3 2013, closing 1 position and reducing 3 holdings. Its most notable exit was Cigna, an estimated $12.3M position sold in full.
By sector, the portfolio is most concentrated in Financials at 49% of assets, down from 50% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Accipiter Capital Management opened a new position in Kindred Healthcare worth $4.91M.
- Accipiter Capital Management's largest Q3 2013 buy was Kindred Healthcare: 365,351 shares worth $4.91M.
- Accipiter Capital Management added most to HP in Q3 2013, an estimated $3.65M increase.
- Accipiter Capital Management's biggest Q3 2013 reduction was Elevance Health, cutting an estimated $6.47M.
- Accipiter Capital Management fully exited Cigna in Q3 2013, selling an estimated $12.3M.
- Accipiter Capital Management's ten largest holdings make up 100% of its $109M portfolio in Q3 2013.
- Accipiter Capital Management opened 2 new positions and closed 1 in Q3 2013.
- Accipiter Capital Management's portfolio value fell 15% quarter-over-quarter to $109M.
Based on Accipiter Capital Management's 13F filing for Q3 2013, filed 14 Nov 2013.